Should we be testing for antiphospholipid antibodies in unexplained pulmonary thromboembolism and atherosclerosis at autopsy?

Christopher Bierton, Neil E I Langlois
Author Information
  1. Christopher Bierton: School of Medicine, University of Adelaide, Frome Road, Adelaide, SA, 5005, Australia.

Abstract

No abstract text available.

References

  1. Immunobiology. 2003;207(1):5-11 [PMID: 12638896]
  2. J Rheumatol. 1995 Jan;22(1):62-6 [PMID: 7699684]
  3. Am J Med. 2000 Dec 1;109(8):635-41 [PMID: 11099683]
  4. Lupus. 2013 Jan;22(1):92-4 [PMID: 23154322]
  5. Ann Intern Med. 1992 Dec 15;117(12):997-1002 [PMID: 1443986]
  6. J Intern Med. 1995 Nov;238(5):437-43 [PMID: 7595183]
  7. J Thromb Haemost. 2006 Feb;4(2):295-306 [PMID: 16420554]
  8. Am J Med. 1996 May;100(5):530-6 [PMID: 8644765]
  9. Circulation. 2005 Jul 19;112(3):e39-44 [PMID: 16027261]

MeSH Term

Antibodies, Antiphospholipid
Antiphospholipid Syndrome
Atherosclerosis
Autopsy
Biomarkers
Cause of Death
Humans
Pulmonary Embolism
Risk Factors

Chemicals

Antibodies, Antiphospholipid
Biomarkers

Word Cloud

Created with Highcharts 10.0.0testingantiphospholipidantibodiesunexplainedpulmonarythromboembolismatherosclerosisautopsy?

Similar Articles

Cited By